ClinicalTrials.Veeva

Menu

Biological Variation of Cardiac Biomarkers in Aortic Valve Stenosis

Maastricht University Medical Centre (MUMC) logo

Maastricht University Medical Centre (MUMC)

Status

Completed

Conditions

Aortic Valve Stenosis

Treatments

Other: No intervention

Study type

Observational

Funder types

Other

Identifiers

NCT02510482
METC 15-2-023

Details and patient eligibility

About

Calcified aortic valve stenosis (CAVS) is a progressive disease and nowadays, the cornerstone in diagnostics and follow-up is echocardiography. Cardiac biomarkers (such as cardiac troponins T and I and NT-pro-BNP) hold promise to fulfil a role in early recognition of complications concerning the aortic valve and decompensation. For this purpose, it is important to assess the normal biological variation (BV) of cardiac biomarkers in CAVS. The assessment of biological variation will contribute to a better understanding of fluctuation of cardiac biomarkers in subjects with stable CAVS. These data will improve monitoring of CAVS using cardiac biomarkers.

Enrollment

25 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Clinically stable moderate aortic valve stenosis
  • No evidence of acute cardiovascular disease

Exclusion criteria

  • Acute myocardial infarction in the last six months
  • Pulmonary embolism in the last six months
  • Hospitalisation for heart failure in the last six months
  • Chronic kidney disease

Trial design

25 participants in 1 patient group

Aortic valve stenosis
Description:
Individuals with clinically stable moderate aortic valve stenosis
Treatment:
Other: No intervention

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems